Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype

Evolutionary functional analysis and molecular regulation of the ZEB transcription factors

(2012) Alexander Gheldof et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype

(2012) Hoiseon Jeong et al.   HISTOPATHOLOGY

Dissecting the Heterogeneity of Triple-Negative Breast Cancer

(2012) Otto Metzger-Filho et al.   JOURNAL OF CLINICAL ONCOLOGY

Overexpression of ZEB1 associated with metastasis and invasion in patients with gastric carcinoma

(2012) Baoqing Jia et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Clinicopathological Significance of ZEB1 Protein in Patients with Hepatocellular Carcinoma

(2011) Yan-Ming Zhou et al.   ANNALS OF SURGICAL ONCOLOGY

Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas

(2011) Peeter Karihtala et al.   BMC CANCER

Transcription factors zeb1, twist and snai1 in breast carcinoma

(2011) Ylermi Soini et al.   BMC CANCER

Zinc finger E-box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial-to-mesenchymal transition

(2011) Zhiyong Liu et al.   CANCER SCIENCE

Epithelial–mesenchymal transition and breast cancer: Role, molecular mechanisms and clinical impact

(2011) Chiara Foroni et al.   CANCER TREATMENT REVIEWS

Molecular heterogeneity of triple-negative breast cancer and its clinical implications

(2011) Sheeba Irshad et al.   CURRENT OPINION IN ONCOLOGY

Nuclear Snail1 and nuclear ZEB1 protein expression in invasive and intraductal human breast carcinomas

(2011) Joseph Geradts et al.   HUMAN PATHOLOGY

p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2

(2011) Taewan Kim et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Estrogen Receptor Silencing Induces Epithelial to Mesenchymal Transition in Human Breast Cancer Cells

(2011) Sanaa Al Saleh et al.   PLoS One

The epithelial-mesenchymal transition (EMT) phenomenon

(2010) P. Savagner   ANNALS OF ONCOLOGY

ZEB1-responsive genes in non-small cell lung cancer

(2010) Robert M. Gemmill et al.   CANCER LETTERS

Challenging Clinical Scenarios: Treatment of Patients With Triple-Negative or Basal-Like Metastatic Breast Cancer

(2010) Sally Greenberg et al.   Clinical Breast Cancer

Focus on Molecules: Smad Interacting Protein 1 (Sip1, ZEB2, ZFHX1B)

(2010) Abby L. Grabitz et al.   EXPERIMENTAL EYE RESEARCH

Zeb1 and twist are more commonly expressed in metastatic than primary lung tumours and show inverse associations with claudins

(2010) H. Merikallio et al.   JOURNAL OF CLINICAL PATHOLOGY

Triple-Negative Breast Cancer

(2010) William D. Foulkes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Does vimentin help to delineate the so-called 'basal type breast cancer'?

(2009) Renata U Kusinska et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The Transcriptional Repressor ZEB1 Promotes Metastasis and Loss of Cell Polarity in Cancer

(2008) S. Spaderna et al.   CANCER RESEARCH

Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype

(2008) D. Sarrio et al.   CANCER RESEARCH

The role of the ZEB family of transcription factors in development and disease

(2008) C. Vandewalle et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

(2008) M. C.U. Cheang et al.   CLINICAL CANCER RESEARCH

Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters

(2008) Maureen Hong-Sing Chen et al.   MODERN PATHOLOGY